GO:1990904 | ribonucleoprotein complex | 34.04% (48/141) | 3.58 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 43.26% (61/141) | 2.86 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 47.52% (67/141) | 2.53 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 57.45% (81/141) | 2.07 | 0.0 | 0.0 |
GO:0006364 | rRNA processing | 22.7% (32/141) | 4.42 | 0.0 | 0.0 |
GO:0016072 | rRNA metabolic process | 23.4% (33/141) | 4.32 | 0.0 | 0.0 |
GO:0030684 | preribosome | 17.02% (24/141) | 5.48 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 29.79% (42/141) | 3.45 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 34.75% (49/141) | 3.01 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 48.23% (68/141) | 2.26 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 26.95% (38/141) | 3.58 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 51.77% (73/141) | 2.07 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 38.3% (54/141) | 2.56 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 48.94% (69/141) | 1.89 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 62.41% (88/141) | 1.48 | 0.0 | 0.0 |
GO:0005730 | nucleolus | 26.95% (38/141) | 2.95 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 39.01% (55/141) | 2.14 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 39.01% (55/141) | 2.14 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 48.94% (69/141) | 1.7 | 0.0 | 0.0 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 9.93% (14/141) | 5.5 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 46.1% (65/141) | 1.66 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 48.94% (69/141) | 1.57 | 0.0 | 0.0 |
GO:0000469 | cleavage involved in rRNA processing | 9.93% (14/141) | 5.21 | 0.0 | 0.0 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.22% (13/141) | 5.48 | 0.0 | 0.0 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 9.93% (14/141) | 4.93 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 61.7% (87/141) | 1.14 | 0.0 | 0.0 |
GO:0009987 | cellular process | 83.69% (118/141) | 0.68 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 54.61% (77/141) | 1.14 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 54.61% (77/141) | 1.13 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 64.54% (91/141) | 0.93 | 0.0 | 0.0 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 9.93% (14/141) | 4.04 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 61.7% (87/141) | 0.95 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 21.28% (30/141) | 2.22 | 0.0 | 0.0 |
GO:1904851 | positive regulation of establishment of protein localization to telomere | 4.26% (6/141) | 7.11 | 0.0 | 0.0 |
GO:0070202 | regulation of establishment of protein localization to chromosome | 4.26% (6/141) | 6.89 | 0.0 | 0.0 |
GO:0070203 | regulation of establishment of protein localization to telomere | 4.26% (6/141) | 6.89 | 0.0 | 0.0 |
GO:1904816 | positive regulation of protein localization to chromosome, telomeric region | 4.26% (6/141) | 6.89 | 0.0 | 0.0 |
GO:0043933 | protein-containing complex organization | 19.15% (27/141) | 2.26 | 0.0 | 0.0 |
GO:1904814 | regulation of protein localization to chromosome, telomeric region | 4.26% (6/141) | 6.7 | 0.0 | 0.0 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 9.93% (14/141) | 3.47 | 0.0 | 0.0 |
GO:0008150 | biological_process | 86.52% (122/141) | 0.49 | 0.0 | 0.0 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.38% (9/141) | 4.71 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 85.82% (121/141) | 0.49 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 63.83% (90/141) | 0.79 | 0.0 | 0.0 |
GO:0030490 | maturation of SSU-rRNA | 6.38% (9/141) | 4.57 | 0.0 | 0.0 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 4.26% (6/141) | 6.18 | 0.0 | 0.0 |
GO:2000573 | positive regulation of DNA biosynthetic process | 5.67% (8/141) | 4.97 | 0.0 | 0.0 |
GO:0005832 | chaperonin-containing T-complex | 3.55% (5/141) | 6.98 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 65.96% (93/141) | 0.73 | 0.0 | 0.0 |
GO:0005488 | binding | 75.89% (107/141) | 0.6 | 0.0 | 0.0 |
GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 4.26% (6/141) | 5.94 | 0.0 | 0.0 |
GO:0030515 | snoRNA binding | 4.96% (7/141) | 5.25 | 0.0 | 0.0 |
GO:0065003 | protein-containing complex assembly | 16.31% (23/141) | 2.23 | 0.0 | 0.0 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.26% (6/141) | 5.84 | 0.0 | 0.0 |
GO:0030687 | preribosome, large subunit precursor | 4.96% (7/141) | 5.09 | 0.0 | 0.0 |
GO:2000278 | regulation of DNA biosynthetic process | 5.67% (8/141) | 4.46 | 0.0 | 0.0 |
GO:0022618 | ribonucleoprotein complex assembly | 8.51% (12/141) | 3.31 | 0.0 | 0.0 |
GO:0042273 | ribosomal large subunit biogenesis | 4.26% (6/141) | 5.41 | 0.0 | 0.0 |
GO:0008135 | translation factor activity, RNA binding | 6.38% (9/141) | 3.98 | 0.0 | 0.0 |
GO:0071826 | ribonucleoprotein complex subunit organization | 8.51% (12/141) | 3.23 | 0.0 | 0.0 |
GO:0022613 | ribonucleoprotein complex biogenesis | 6.38% (9/141) | 3.94 | 0.0 | 0.0 |
GO:0032210 | regulation of telomere maintenance via telomerase | 4.26% (6/141) | 5.21 | 0.0 | 0.0 |
GO:0007339 | binding of sperm to zona pellucida | 3.55% (5/141) | 5.98 | 0.0 | 0.0 |
GO:0035036 | sperm-egg recognition | 3.55% (5/141) | 5.98 | 0.0 | 0.0 |
GO:0006412 | translation | 9.22% (13/141) | 2.95 | 0.0 | 0.0 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 2.84% (4/141) | 6.94 | 0.0 | 1e-06 |
GO:0003674 | molecular_function | 81.56% (115/141) | 0.45 | 0.0 | 1e-06 |
GO:0019843 | rRNA binding | 7.09% (10/141) | 3.51 | 0.0 | 1e-06 |
GO:0044391 | ribosomal subunit | 8.51% (12/141) | 3.07 | 0.0 | 1e-06 |
GO:0043226 | organelle | 63.12% (89/141) | 0.65 | 0.0 | 1e-06 |
GO:0140535 | intracellular protein-containing complex | 12.77% (18/141) | 2.3 | 0.0 | 1e-06 |
GO:0032040 | small-subunit processome | 4.26% (6/141) | 5.03 | 0.0 | 1e-06 |
GO:0043043 | peptide biosynthetic process | 9.22% (13/141) | 2.87 | 0.0 | 1e-06 |
GO:0009988 | cell-cell recognition | 3.55% (5/141) | 5.68 | 0.0 | 1e-06 |
GO:0032206 | positive regulation of telomere maintenance | 4.26% (6/141) | 4.92 | 0.0 | 1e-06 |
GO:1903829 | positive regulation of protein localization | 7.09% (10/141) | 3.37 | 0.0 | 1e-06 |
GO:0090079 | translation regulator activity, nucleic acid binding | 6.38% (9/141) | 3.62 | 0.0 | 1e-06 |
GO:0034645 | cellular macromolecule biosynthetic process | 12.06% (17/141) | 2.32 | 0.0 | 1e-06 |
GO:1904356 | regulation of telomere maintenance via telomere lengthening | 4.26% (6/141) | 4.84 | 0.0 | 2e-06 |
GO:0101031 | chaperone complex | 4.26% (6/141) | 4.82 | 0.0 | 2e-06 |
GO:0000966 | RNA 5'-end processing | 4.26% (6/141) | 4.79 | 0.0 | 2e-06 |
GO:0043604 | amide biosynthetic process | 9.93% (14/141) | 2.55 | 0.0 | 3e-06 |
GO:0043229 | intracellular organelle | 61.7% (87/141) | 0.63 | 0.0 | 3e-06 |
GO:0003729 | mRNA binding | 15.6% (22/141) | 1.87 | 0.0 | 3e-06 |
GO:0030150 | protein import into mitochondrial matrix | 3.55% (5/141) | 5.31 | 0.0 | 4e-06 |
GO:0044183 | protein folding chaperone | 4.26% (6/141) | 4.57 | 0.0 | 4e-06 |
GO:0016282 | eukaryotic 43S preinitiation complex | 3.55% (5/141) | 5.19 | 0.0 | 5e-06 |
GO:0098798 | mitochondrial protein-containing complex | 6.38% (9/141) | 3.37 | 0.0 | 5e-06 |
GO:0003735 | structural constituent of ribosome | 7.8% (11/141) | 2.91 | 0.0 | 6e-06 |
GO:0110165 | cellular anatomical entity | 80.14% (113/141) | 0.41 | 0.0 | 6e-06 |
GO:0071840 | cellular component organization or biogenesis | 34.75% (49/141) | 1.0 | 1e-06 | 1e-05 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.84% (4/141) | 5.87 | 1e-06 | 1.2e-05 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 4.96% (7/141) | 3.86 | 1e-06 | 1.2e-05 |
GO:0009059 | macromolecule biosynthetic process | 14.18% (20/141) | 1.85 | 1e-06 | 1.3e-05 |
GO:0022607 | cellular component assembly | 18.44% (26/141) | 1.54 | 1e-06 | 1.5e-05 |
GO:1901998 | toxin transport | 3.55% (5/141) | 4.85 | 1e-06 | 1.6e-05 |
GO:0000967 | rRNA 5'-end processing | 2.84% (4/141) | 5.72 | 1e-06 | 1.6e-05 |
GO:0034471 | ncRNA 5'-end processing | 2.84% (4/141) | 5.72 | 1e-06 | 1.6e-05 |
GO:0090670 | RNA localization to Cajal body | 2.13% (3/141) | 7.11 | 1e-06 | 1.6e-05 |
GO:0090685 | RNA localization to nucleus | 2.13% (3/141) | 7.11 | 1e-06 | 1.6e-05 |
GO:0070125 | mitochondrial translational elongation | 2.13% (3/141) | 7.11 | 1e-06 | 1.6e-05 |
GO:0045182 | translation regulator activity | 6.38% (9/141) | 3.15 | 1e-06 | 1.6e-05 |
GO:0070993 | translation preinitiation complex | 3.55% (5/141) | 4.82 | 1e-06 | 1.6e-05 |
GO:0032204 | regulation of telomere maintenance | 4.26% (6/141) | 4.11 | 1e-06 | 2.4e-05 |
GO:0006518 | peptide metabolic process | 9.22% (13/141) | 2.37 | 2e-06 | 2.7e-05 |
GO:0051054 | positive regulation of DNA metabolic process | 5.67% (8/141) | 3.31 | 2e-06 | 2.7e-05 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 2.84% (4/141) | 5.41 | 2e-06 | 3.8e-05 |
GO:0001732 | formation of cytoplasmic translation initiation complex | 2.84% (4/141) | 5.36 | 3e-06 | 4.4e-05 |
GO:0005739 | mitochondrion | 15.6% (22/141) | 1.6 | 3e-06 | 5.1e-05 |
GO:2001252 | positive regulation of chromosome organization | 4.26% (6/141) | 3.91 | 3e-06 | 5.3e-05 |
GO:0036260 | RNA capping | 2.84% (4/141) | 5.26 | 4e-06 | 5.7e-05 |
GO:0000470 | maturation of LSU-rRNA | 3.55% (5/141) | 4.44 | 4e-06 | 5.7e-05 |
GO:1904951 | positive regulation of establishment of protein localization | 4.96% (7/141) | 3.45 | 4e-06 | 6.4e-05 |
GO:0008037 | cell recognition | 4.26% (6/141) | 3.84 | 4e-06 | 6.6e-05 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 10.64% (15/141) | 2.04 | 4e-06 | 6.6e-05 |
GO:0044743 | protein transmembrane import into intracellular organelle | 3.55% (5/141) | 4.37 | 5e-06 | 7e-05 |
GO:0033290 | eukaryotic 48S preinitiation complex | 2.84% (4/141) | 5.07 | 6e-06 | 9.2e-05 |
GO:0140513 | nuclear protein-containing complex | 12.77% (18/141) | 1.75 | 7e-06 | 0.000109 |
GO:0008380 | RNA splicing | 6.38% (9/141) | 2.77 | 8e-06 | 0.00012 |
GO:0051082 | unfolded protein binding | 4.96% (7/141) | 3.29 | 8e-06 | 0.000124 |
GO:0140098 | catalytic activity, acting on RNA | 8.51% (12/141) | 2.25 | 1e-05 | 0.00014 |
GO:0005198 | structural molecule activity | 7.8% (11/141) | 2.38 | 1e-05 | 0.000144 |
GO:0044260 | cellular macromolecule metabolic process | 20.57% (29/141) | 1.23 | 1.2e-05 | 0.000174 |
GO:0016275 | obsolete [cytochrome c]-arginine N-methyltransferase activity | 1.42% (2/141) | 8.11 | 1.3e-05 | 0.000181 |
GO:0030689 | Noc complex | 1.42% (2/141) | 8.11 | 1.3e-05 | 0.000181 |
GO:0031681 | G-protein beta-subunit binding | 1.42% (2/141) | 8.11 | 1.3e-05 | 0.000181 |
GO:0005732 | sno(s)RNA-containing ribonucleoprotein complex | 2.84% (4/141) | 4.76 | 1.5e-05 | 0.000205 |
GO:0030686 | 90S preribosome | 2.13% (3/141) | 5.89 | 1.6e-05 | 0.000222 |
GO:0040031 | snRNA modification | 2.13% (3/141) | 5.89 | 1.6e-05 | 0.000222 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.84% (4/141) | 4.69 | 1.8e-05 | 0.000243 |
GO:0072655 | establishment of protein localization to mitochondrion | 3.55% (5/141) | 3.96 | 1.9e-05 | 0.000249 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.13% (3/141) | 5.79 | 2e-05 | 0.00027 |
GO:0016043 | cellular component organization | 30.5% (43/141) | 0.9 | 2.1e-05 | 0.000276 |
GO:0070585 | protein localization to mitochondrion | 3.55% (5/141) | 3.91 | 2.2e-05 | 0.000286 |
GO:0030688 | preribosome, small subunit precursor | 2.13% (3/141) | 5.7 | 2.5e-05 | 0.000324 |
GO:0003743 | translation initiation factor activity | 3.55% (5/141) | 3.84 | 2.8e-05 | 0.000364 |
GO:0050821 | protein stabilization | 4.96% (7/141) | 3.01 | 2.9e-05 | 0.000372 |
GO:0043603 | cellular amide metabolic process | 9.93% (14/141) | 1.88 | 2.9e-05 | 0.000373 |
GO:0015934 | large ribosomal subunit | 4.96% (7/141) | 3.0 | 3e-05 | 0.000379 |
GO:0005744 | TIM23 mitochondrial import inner membrane translocase complex | 2.13% (3/141) | 5.61 | 3e-05 | 0.000379 |
GO:0051052 | regulation of DNA metabolic process | 7.09% (10/141) | 2.34 | 3.2e-05 | 0.000405 |
GO:0006457 | protein folding | 5.67% (8/141) | 2.71 | 3.4e-05 | 0.000426 |
GO:0006403 | RNA localization | 2.84% (4/141) | 4.44 | 3.6e-05 | 0.000438 |
GO:0030519 | snoRNP binding | 1.42% (2/141) | 7.53 | 3.9e-05 | 0.000454 |
GO:0030917 | midbrain-hindbrain boundary development | 1.42% (2/141) | 7.53 | 3.9e-05 | 0.000454 |
GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane | 1.42% (2/141) | 7.53 | 3.9e-05 | 0.000454 |
GO:0048273 | mitogen-activated protein kinase p38 binding | 1.42% (2/141) | 7.53 | 3.9e-05 | 0.000454 |
GO:0098753 | anchored component of the cytoplasmic side of the plasma membrane | 1.42% (2/141) | 7.53 | 3.9e-05 | 0.000454 |
GO:1905909 | regulation of dauer entry | 1.42% (2/141) | 7.53 | 3.9e-05 | 0.000454 |
GO:0000027 | ribosomal large subunit assembly | 2.84% (4/141) | 4.41 | 3.8e-05 | 0.00047 |
GO:0006839 | mitochondrial transport | 3.55% (5/141) | 3.7 | 4.5e-05 | 0.000525 |
GO:1990542 | mitochondrial transmembrane transport | 3.55% (5/141) | 3.63 | 5.6e-05 | 0.000649 |
GO:0032880 | regulation of protein localization | 7.09% (10/141) | 2.24 | 5.8e-05 | 0.000662 |
GO:0065002 | intracellular protein transmembrane transport | 3.55% (5/141) | 3.62 | 5.8e-05 | 0.000664 |
GO:0005856 | cytoskeleton | 7.09% (10/141) | 2.24 | 5.8e-05 | 0.000667 |
GO:0008320 | protein transmembrane transporter activity | 2.84% (4/141) | 4.23 | 6.3e-05 | 0.000715 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 13.48% (19/141) | 1.44 | 7.5e-05 | 0.000837 |
GO:0044020 | histone methyltransferase activity (H4-R3 specific) | 1.42% (2/141) | 7.11 | 7.7e-05 | 0.00085 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 1.42% (2/141) | 7.11 | 7.7e-05 | 0.00085 |
GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome | 1.42% (2/141) | 7.11 | 7.7e-05 | 0.00085 |
GO:0022884 | macromolecule transmembrane transporter activity | 2.84% (4/141) | 4.11 | 8.7e-05 | 0.000954 |
GO:0099080 | supramolecular complex | 9.22% (13/141) | 1.81 | 9.4e-05 | 0.001025 |
GO:0008173 | RNA methyltransferase activity | 2.84% (4/141) | 4.05 | 0.000104 | 0.001127 |
GO:0090666 | scaRNA localization to Cajal body | 1.42% (2/141) | 6.79 | 0.000128 | 0.001345 |
GO:1904874 | positive regulation of telomerase RNA localization to Cajal body | 1.42% (2/141) | 6.79 | 0.000128 | 0.001345 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.42% (2/141) | 6.79 | 0.000128 | 0.001345 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.42% (2/141) | 6.79 | 0.000128 | 0.001345 |
GO:0071540 | eukaryotic translation initiation factor 3 complex, eIF3e | 1.42% (2/141) | 6.79 | 0.000128 | 0.001345 |
GO:0071806 | protein transmembrane transport | 3.55% (5/141) | 3.37 | 0.000131 | 0.001363 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4.96% (7/141) | 2.62 | 0.000158 | 0.001641 |
GO:0031369 | translation initiation factor binding | 2.84% (4/141) | 3.89 | 0.000162 | 0.001666 |
GO:0051973 | positive regulation of telomerase activity | 2.13% (3/141) | 4.79 | 0.000174 | 0.001779 |
GO:1902494 | catalytic complex | 12.77% (18/141) | 1.39 | 0.000175 | 0.001786 |
GO:0140318 | protein transporter activity | 2.84% (4/141) | 3.85 | 0.000179 | 0.001812 |
GO:1904872 | regulation of telomerase RNA localization to Cajal body | 1.42% (2/141) | 6.53 | 0.000192 | 0.001911 |
GO:0043985 | histone H4-R3 methylation | 1.42% (2/141) | 6.53 | 0.000192 | 0.001911 |
GO:0014706 | striated muscle tissue development | 2.13% (3/141) | 4.75 | 0.000192 | 0.001931 |
GO:0099081 | supramolecular polymer | 6.38% (9/141) | 2.17 | 0.000199 | 0.001956 |
GO:0099512 | supramolecular fiber | 6.38% (9/141) | 2.17 | 0.000199 | 0.001956 |
GO:0043021 | ribonucleoprotein complex binding | 4.26% (6/141) | 2.85 | 0.000201 | 0.001971 |
GO:0015630 | microtubule cytoskeleton | 3.55% (5/141) | 3.23 | 0.000208 | 0.002024 |
GO:0005874 | microtubule | 5.67% (8/141) | 2.33 | 0.000214 | 0.002076 |
GO:0060341 | regulation of cellular localization | 7.09% (10/141) | 2.0 | 0.000217 | 0.002087 |
GO:0001510 | RNA methylation | 2.84% (4/141) | 3.76 | 0.000228 | 0.002185 |
GO:0008097 | 5S rRNA binding | 2.13% (3/141) | 4.66 | 0.000232 | 0.002205 |
GO:0008469 | histone-arginine N-methyltransferase activity | 1.42% (2/141) | 6.31 | 0.000268 | 0.0025 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.42% (2/141) | 6.31 | 0.000268 | 0.0025 |
GO:0035241 | protein-arginine omega-N monomethyltransferase activity | 1.42% (2/141) | 6.31 | 0.000268 | 0.0025 |
GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity | 1.42% (2/141) | 6.31 | 0.000268 | 0.0025 |
GO:0070201 | regulation of establishment of protein localization | 4.96% (7/141) | 2.49 | 0.000275 | 0.002549 |
GO:0005515 | protein binding | 52.48% (74/141) | 0.47 | 0.000288 | 0.002659 |
GO:0005815 | microtubule organizing center | 5.67% (8/141) | 2.26 | 0.000297 | 0.002725 |
GO:0015935 | small ribosomal subunit | 3.55% (5/141) | 3.09 | 0.000325 | 0.002964 |
GO:0032553 | ribonucleotide binding | 14.89% (21/141) | 1.19 | 0.000331 | 0.003003 |
GO:0050897 | cobalt ion binding | 2.84% (4/141) | 3.61 | 0.00034 | 0.003072 |
GO:0002199 | zona pellucida receptor complex | 1.42% (2/141) | 6.11 | 0.000357 | 0.003206 |
GO:0061062 | regulation of nematode larval development | 2.13% (3/141) | 4.38 | 0.000412 | 0.003682 |
GO:0009451 | RNA modification | 6.38% (9/141) | 2.02 | 0.00042 | 0.003735 |
GO:0051972 | regulation of telomerase activity | 2.13% (3/141) | 4.34 | 0.000443 | 0.003922 |
GO:0075522 | IRES-dependent viral translational initiation | 1.42% (2/141) | 5.94 | 0.000457 | 0.003971 |
GO:0061065 | regulation of dauer larval development | 1.42% (2/141) | 5.94 | 0.000457 | 0.003971 |
GO:0060322 | head development | 1.42% (2/141) | 5.94 | 0.000457 | 0.003971 |
GO:0120293 | dynein axonemal particle | 1.42% (2/141) | 5.94 | 0.000457 | 0.003971 |
GO:0003746 | translation elongation factor activity | 2.13% (3/141) | 4.31 | 0.000476 | 0.00411 |
GO:0031647 | regulation of protein stability | 4.96% (7/141) | 2.33 | 0.000528 | 0.00454 |
GO:0035246 | peptidyl-arginine N-methylation | 1.42% (2/141) | 5.79 | 0.00057 | 0.004856 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 1.42% (2/141) | 5.79 | 0.00057 | 0.004856 |
GO:0032555 | purine ribonucleotide binding | 14.18% (20/141) | 1.16 | 0.000607 | 0.005143 |
GO:0035639 | purine ribonucleoside triphosphate binding | 13.48% (19/141) | 1.2 | 0.000626 | 0.005281 |
GO:0017076 | purine nucleotide binding | 14.18% (20/141) | 1.15 | 0.000658 | 0.005519 |
GO:0016273 | arginine N-methyltransferase activity | 1.42% (2/141) | 5.66 | 0.000696 | 0.005701 |
GO:0016274 | protein-arginine N-methyltransferase activity | 1.42% (2/141) | 5.66 | 0.000696 | 0.005701 |
GO:1904047 | S-adenosyl-L-methionine binding | 1.42% (2/141) | 5.66 | 0.000696 | 0.005701 |
GO:0097367 | carbohydrate derivative binding | 14.89% (21/141) | 1.11 | 0.000688 | 0.005745 |
GO:0099513 | polymeric cytoskeletal fiber | 5.67% (8/141) | 2.07 | 0.000694 | 0.00577 |
GO:0033044 | regulation of chromosome organization | 4.26% (6/141) | 2.48 | 0.000774 | 0.006314 |
GO:0034969 | histone arginine methylation | 1.42% (2/141) | 5.53 | 0.000833 | 0.006731 |
GO:0034511 | U3 snoRNA binding | 1.42% (2/141) | 5.53 | 0.000833 | 0.006731 |
GO:0032259 | methylation | 5.67% (8/141) | 2.0 | 0.000968 | 0.007786 |
GO:0070034 | telomerase RNA binding | 1.42% (2/141) | 5.41 | 0.000982 | 0.007864 |
GO:0044085 | cellular component biogenesis | 6.38% (9/141) | 1.84 | 0.001026 | 0.008182 |
GO:0060537 | muscle tissue development | 2.13% (3/141) | 3.89 | 0.001107 | 0.008749 |
GO:0097421 | liver regeneration | 2.13% (3/141) | 3.89 | 0.001107 | 0.008749 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.42% (2/141) | 5.31 | 0.001143 | 0.008949 |
GO:0005763 | mitochondrial small ribosomal subunit | 1.42% (2/141) | 5.31 | 0.001143 | 0.008949 |
GO:0016073 | snRNA metabolic process | 2.13% (3/141) | 3.82 | 0.001288 | 0.010045 |
GO:0018216 | peptidyl-arginine methylation | 1.42% (2/141) | 5.21 | 0.001315 | 0.010122 |
GO:0045446 | endothelial cell differentiation | 1.42% (2/141) | 5.21 | 0.001315 | 0.010122 |
GO:0042274 | ribosomal small subunit biogenesis | 1.42% (2/141) | 5.21 | 0.001315 | 0.010122 |
GO:0001889 | liver development | 2.84% (4/141) | 3.07 | 0.001371 | 0.010507 |
GO:0000151 | ubiquitin ligase complex | 4.96% (7/141) | 2.09 | 0.00139 | 0.010602 |
GO:0044877 | protein-containing complex binding | 7.8% (11/141) | 1.56 | 0.001398 | 0.010617 |
GO:0000314 | organellar small ribosomal subunit | 1.42% (2/141) | 5.11 | 0.0015 | 0.011342 |
GO:0032268 | regulation of cellular protein metabolic process | 2.13% (3/141) | 3.72 | 0.001557 | 0.011727 |
GO:0005840 | ribosome | 4.96% (7/141) | 2.05 | 0.001591 | 0.011932 |
GO:0018195 | peptidyl-arginine modification | 1.42% (2/141) | 5.03 | 0.001696 | 0.012555 |
GO:0031428 | box C/D RNP complex | 1.42% (2/141) | 5.03 | 0.001696 | 0.012555 |
GO:1900182 | positive regulation of protein localization to nucleus | 2.13% (3/141) | 3.68 | 0.001704 | 0.012563 |
GO:0051641 | cellular localization | 12.77% (18/141) | 1.11 | 0.001688 | 0.012604 |
GO:0006913 | nucleocytoplasmic transport | 3.55% (5/141) | 2.52 | 0.001872 | 0.013743 |
GO:0005742 | mitochondrial outer membrane translocase complex | 1.42% (2/141) | 4.94 | 0.001903 | 0.013801 |
GO:0098799 | outer mitochondrial membrane protein complex | 1.42% (2/141) | 4.94 | 0.001903 | 0.013801 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 1.42% (2/141) | 4.94 | 0.001903 | 0.013801 |
GO:0051169 | nuclear transport | 3.55% (5/141) | 2.51 | 0.00194 | 0.014013 |
GO:1990234 | transferase complex | 7.8% (11/141) | 1.49 | 0.001964 | 0.014123 |
GO:0008168 | methyltransferase activity | 4.96% (7/141) | 1.99 | 0.002016 | 0.014378 |
GO:0032559 | adenyl ribonucleotide binding | 12.06% (17/141) | 1.13 | 0.002013 | 0.014419 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 12.06% (17/141) | 1.12 | 0.002082 | 0.014796 |
GO:0030554 | adenyl nucleotide binding | 12.06% (17/141) | 1.12 | 0.002123 | 0.014903 |
GO:0051168 | nuclear export | 2.84% (4/141) | 2.9 | 0.002135 | 0.014931 |
GO:0034709 | methylosome | 1.42% (2/141) | 4.87 | 0.002122 | 0.014957 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.42% (2/141) | 4.87 | 0.002122 | 0.014957 |
GO:0048513 | animal organ development | 7.8% (11/141) | 1.46 | 0.002326 | 0.0162 |
GO:0048738 | cardiac muscle tissue development | 1.42% (2/141) | 4.79 | 0.002352 | 0.016319 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 4.26% (6/141) | 2.16 | 0.002384 | 0.016343 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 2.13% (3/141) | 3.51 | 0.002376 | 0.016354 |
GO:0005524 | ATP binding | 11.35% (16/141) | 1.15 | 0.002367 | 0.016358 |
GO:0034708 | methyltransferase complex | 2.84% (4/141) | 2.85 | 0.002406 | 0.016435 |
GO:0000049 | tRNA binding | 2.13% (3/141) | 3.49 | 0.00247 | 0.016739 |
GO:0043414 | macromolecule methylation | 4.26% (6/141) | 2.15 | 0.00248 | 0.016746 |
GO:0016741 | transferase activity, transferring one-carbon groups | 4.96% (7/141) | 1.94 | 0.002468 | 0.016788 |
GO:0010638 | positive regulation of organelle organization | 4.26% (6/141) | 2.13 | 0.002648 | 0.01781 |
GO:0007444 | imaginal disc development | 1.42% (2/141) | 4.66 | 0.002847 | 0.018856 |
GO:0005762 | mitochondrial large ribosomal subunit | 1.42% (2/141) | 4.66 | 0.002847 | 0.018856 |
GO:0006337 | nucleosome disassembly | 1.42% (2/141) | 4.66 | 0.002847 | 0.018856 |
GO:0032543 | mitochondrial translation | 1.42% (2/141) | 4.66 | 0.002847 | 0.018856 |
GO:0008340 | determination of adult lifespan | 2.84% (4/141) | 2.78 | 0.002888 | 0.019059 |
GO:0140101 | catalytic activity, acting on a tRNA | 3.55% (5/141) | 2.37 | 0.003007 | 0.019771 |
GO:0031100 | animal organ regeneration | 2.13% (3/141) | 3.38 | 0.003082 | 0.020186 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.42% (2/141) | 4.59 | 0.00311 | 0.020223 |
GO:0000460 | maturation of 5.8S rRNA | 1.42% (2/141) | 4.59 | 0.00311 | 0.020223 |
GO:0003924 | GTPase activity | 3.55% (5/141) | 2.34 | 0.003203 | 0.020746 |
GO:0042000 | translocation of peptides or proteins into host | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0044053 | translocation of peptides or proteins into host cell cytoplasm | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0048794 | swim bladder development | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:1903405 | protein localization to nuclear body | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:1904867 | protein localization to Cajal body | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:1990173 | protein localization to nucleoplasm | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0030690 | Noc1p-Noc2p complex | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0030691 | Noc2p-Noc3p complex | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0000495 | box H/ACA RNA 3'-end processing | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0034964 | box H/ACA RNA processing | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:1990417 | snoRNA release from pre-rRNA | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0000465 | exonucleolytic trimming to generate mature 5'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0097344 | Rix1 complex | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:1902184 | negative regulation of shoot apical meristem development | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0004164 | diphthine synthase activity | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:1990276 | RNA 5'-methyltransferase activity | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0070476 | rRNA (guanine-N7)-methylation | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0030240 | skeletal muscle thin filament assembly | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0042749 | regulation of circadian sleep/wake cycle | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0048769 | sarcomerogenesis | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0102521 | tRNA-4-demethylwyosine synthase activity | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0030692 | Noc4p-Nop14p complex | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0052905 | tRNA (guanine(9)-N(1))-methyltransferase activity | 0.71% (1/141) | 8.11 | 0.003607 | 0.020839 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 4.26% (6/141) | 2.07 | 0.003243 | 0.020852 |
GO:0032879 | regulation of localization | 10.64% (15/141) | 1.15 | 0.003238 | 0.020897 |
GO:0045638 | negative regulation of myeloid cell differentiation | 1.42% (2/141) | 4.47 | 0.003671 | 0.021068 |
GO:0016444 | somatic cell DNA recombination | 1.42% (2/141) | 4.47 | 0.003671 | 0.021068 |
GO:0010197 | polar nucleus fusion | 2.13% (3/141) | 3.34 | 0.003304 | 0.021172 |
GO:0006399 | tRNA metabolic process | 4.26% (6/141) | 2.06 | 0.003323 | 0.021217 |
GO:0043168 | anion binding | 15.6% (22/141) | 0.88 | 0.003753 | 0.021471 |
GO:0035578 | azurophil granule lumen | 1.42% (2/141) | 4.53 | 0.003385 | 0.021532 |
GO:0046907 | intracellular transport | 8.51% (12/141) | 1.3 | 0.003786 | 0.021589 |
GO:0044297 | cell body | 3.55% (5/141) | 2.32 | 0.003407 | 0.021593 |
GO:0004386 | helicase activity | 3.55% (5/141) | 2.28 | 0.003844 | 0.021846 |
GO:0006414 | translational elongation | 2.13% (3/141) | 3.31 | 0.003537 | 0.022336 |
GO:0000741 | karyogamy | 2.13% (3/141) | 3.24 | 0.004031 | 0.022837 |
GO:0000166 | nucleotide binding | 17.73% (25/141) | 0.8 | 0.004076 | 0.022945 |
GO:1901265 | nucleoside phosphate binding | 17.73% (25/141) | 0.8 | 0.004076 | 0.022945 |
GO:0009553 | embryo sac development | 2.84% (4/141) | 2.59 | 0.004544 | 0.025496 |
GO:1900745 | positive regulation of p38MAPK cascade | 1.42% (2/141) | 4.31 | 0.004593 | 0.025608 |
GO:0000315 | organellar large ribosomal subunit | 1.42% (2/141) | 4.31 | 0.004593 | 0.025608 |
GO:0008033 | tRNA processing | 3.55% (5/141) | 2.22 | 0.004637 | 0.025771 |
GO:0005694 | chromosome | 4.96% (7/141) | 1.77 | 0.004688 | 0.025974 |
GO:0042981 | regulation of apoptotic process | 5.67% (8/141) | 1.6 | 0.005313 | 0.029345 |
GO:0005813 | centrosome | 3.55% (5/141) | 2.17 | 0.005393 | 0.029696 |
GO:0051019 | mitogen-activated protein kinase binding | 1.42% (2/141) | 4.16 | 0.00561 | 0.030793 |
GO:0046686 | response to cadmium ion | 6.38% (9/141) | 1.46 | 0.005834 | 0.031924 |
GO:0051171 | regulation of nitrogen compound metabolic process | 22.7% (32/141) | 0.64 | 0.006312 | 0.034325 |
GO:0048732 | gland development | 2.84% (4/141) | 2.46 | 0.006299 | 0.034363 |
GO:1900744 | regulation of p38MAPK cascade | 1.42% (2/141) | 4.07 | 0.00634 | 0.034372 |
GO:0022625 | cytosolic large ribosomal subunit | 2.84% (4/141) | 2.45 | 0.006408 | 0.034636 |
GO:0008327 | methyl-CpG binding | 1.42% (2/141) | 4.03 | 0.00672 | 0.035882 |
GO:0032986 | protein-DNA complex disassembly | 1.42% (2/141) | 4.03 | 0.00672 | 0.035882 |
GO:0000054 | ribosomal subunit export from nucleus | 1.42% (2/141) | 4.03 | 0.00672 | 0.035882 |
GO:0033750 | ribosome localization | 1.42% (2/141) | 4.03 | 0.00672 | 0.035882 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 11.35% (16/141) | 0.99 | 0.006806 | 0.036229 |
GO:0034396 | negative regulation of transcription from RNA polymerase II promoter in response to iron | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:2000109 | regulation of macrophage apoptotic process | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:1990226 | histone methyltransferase binding | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0004730 | pseudouridylate synthase activity | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0033979 | box H/ACA RNA metabolic process | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0110136 | protein-RNA complex remodeling | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:1904869 | regulation of protein localization to Cajal body | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:1904871 | positive regulation of protein localization to Cajal body | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0070094 | positive regulation of glucagon secretion | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0031590 | wybutosine metabolic process | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0031591 | wybutosine biosynthetic process | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0005134 | interleukin-2 receptor binding | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:1900052 | regulation of retinoic acid biosynthetic process | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:1900053 | negative regulation of retinoic acid biosynthetic process | 0.71% (1/141) | 7.11 | 0.007202 | 0.036463 |
GO:0031328 | positive regulation of cellular biosynthetic process | 12.06% (17/141) | 0.95 | 0.007127 | 0.037712 |
GO:1900180 | regulation of protein localization to nucleus | 2.13% (3/141) | 2.94 | 0.007117 | 0.037774 |
GO:0006928 | obsolete movement of cell or subcellular component | 1.42% (2/141) | 3.94 | 0.007511 | 0.037815 |
GO:0048487 | beta-tubulin binding | 1.42% (2/141) | 3.94 | 0.007511 | 0.037815 |
GO:1901566 | organonitrogen compound biosynthetic process | 11.35% (16/141) | 0.97 | 0.00763 | 0.038302 |
GO:0007017 | microtubule-based process | 5.67% (8/141) | 1.5 | 0.007776 | 0.038925 |
GO:0045747 | positive regulation of Notch signaling pathway | 1.42% (2/141) | 3.91 | 0.007922 | 0.039543 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.13% (3/141) | 2.88 | 0.008057 | 0.040103 |
GO:0009891 | positive regulation of biosynthetic process | 12.06% (17/141) | 0.92 | 0.008409 | 0.041738 |
GO:0001701 | in utero embryonic development | 2.13% (3/141) | 2.84 | 0.008654 | 0.042833 |
GO:0045646 | regulation of erythrocyte differentiation | 1.42% (2/141) | 3.83 | 0.008773 | 0.043178 |
GO:0050900 | leukocyte migration | 1.42% (2/141) | 3.83 | 0.008773 | 0.043178 |
GO:0045639 | positive regulation of myeloid cell differentiation | 1.42% (2/141) | 3.79 | 0.009213 | 0.045218 |
GO:0048522 | positive regulation of cellular process | 21.28% (30/141) | 0.62 | 0.010039 | 0.049134 |
GO:0016462 | pyrophosphatase activity | 4.26% (6/141) | 1.72 | 0.010159 | 0.04931 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 2.13% (3/141) | 2.76 | 0.010146 | 0.049386 |
GO:0003730 | mRNA 3'-UTR binding | 2.13% (3/141) | 2.76 | 0.010146 | 0.049386 |
GO:0051661 | maintenance of centrosome location | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0075525 | viral translational termination-reinitiation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0000454 | snoRNA guided rRNA pseudouridine synthesis | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0090661 | box H/ACA telomerase RNP complex | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0001826 | inner cell mass cell differentiation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0000464 | endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:1905380 | regulation of snRNA transcription by RNA polymerase II | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:1905382 | positive regulation of snRNA transcription by RNA polymerase II | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0004831 | tyrosine-tRNA ligase activity | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0070092 | regulation of glucagon secretion | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:2000269 | regulation of fibroblast apoptotic process | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0036265 | RNA (guanine-N7)-methylation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0002276 | basophil activation involved in immune response | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0003877 | ATP adenylyltransferase activity | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0043032 | positive regulation of macrophage activation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0045575 | basophil activation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0002939 | tRNA N1-guanine methylation | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity | 0.71% (1/141) | 6.53 | 0.010783 | 0.049608 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.26% (6/141) | 1.7 | 0.010818 | 0.049641 |